Unravelling the behavioural and molecular hallmarks of Spinocerebellar Ataxia type 17 (SCA17). Studies on a transgenic rat model
暂无分享,去创建一个
[1] I. Loubinoux,et al. Focal Malonate Injection Into the Internal Capsule of Rats as a Model of Lacunar Stroke , 2018, Front. Neurol..
[2] K. Kondrakiewicz,et al. Ecological validity of social interaction tests in rats and mice , 2018, Genes, brain, and behavior.
[3] P. Dijkers,et al. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons , 2018, Journal of Neuroinflammation.
[4] H. Paulson,et al. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice , 2018, Annals of neurology.
[5] H. Petry,et al. AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] S. Peters. The importance of rat social behavior for translational research : An ethological approach , 2018 .
[7] Claudia Mazzà,et al. A systematic review of the gait characteristics associated with Cerebellar Ataxia. , 2018, Gait & posture.
[8] Zhen Li,et al. Social interaction with a cagemate in pain increases allogrooming and induces pain hypersensitivity in the observer rats , 2018, Neuroscience Letters.
[9] M. T. Lorbach,et al. Automated Recognition of Rodent Social Behavior , 2017 .
[10] Elisavet I. Kyriakou,et al. The BACHD Rat Model of Huntington Disease Shows Specific Deficits in a Test Battery of Motor Function , 2017, Front. Behav. Neurosci..
[11] Yan Wang,et al. The Locus Coeruleus–Norepinephrine System Mediates Empathy for Pain through Selective Up-Regulation of P2X3 Receptor in Dorsal Root Ganglia in Rats , 2017, Front. Neural Circuits.
[12] Elisavet I. Kyriakou,et al. Home-cage anxiety levels in a transgenic rat model for Spinocerebellar ataxia type 17 measured by an approach-avoidance task: The light spot test , 2017, Journal of Neuroscience Methods.
[13] Shihua Li,et al. Genetically modified rodent models of SCA17 , 2017, Journal of neuroscience research.
[14] H. van Attikum,et al. Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice , 2017, Molecular therapy. Nucleic acids.
[15] Elisavet I. Kyriakou,et al. Learning to recognize rat social behavior: Novel dataset and cross-dataset application , 2017, Journal of Neuroscience Methods.
[16] Rowland R. Sillito,et al. Assessing mouse behaviour throughout the light/dark cycle using automated in-cage analysis tools , 2017, Journal of Neuroscience Methods.
[17] P. Bauer,et al. Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat , 2017, Journal of psychopharmacology.
[18] Elisavet I. Kyriakou,et al. Anxiety and risk assessment-related traits in a rat model of Spinocerebellar ataxia type 17 , 2017, Behavioural Brain Research.
[19] J. Homberg,et al. Comeback of the Rat in Biomedical Research. , 2017, ACS chemical neuroscience.
[20] N. Sousa,et al. PhenoWorld: addressing animal welfare in a new paradigm to house and assess rat behaviour , 2017, Laboratory animals.
[21] Kristin Branson,et al. Machine vision methods for analyzing social interactions , 2017, Journal of Experimental Biology.
[22] H. Würbel,et al. The Researchers’ View of Scientific Rigor—Survey on the Conduct and Reporting of In Vivo Research , 2016, PloS one.
[23] Jeremy D. Schmahmann,et al. Cerebellar Contribution to Social Cognition , 2016, The Cerebellum.
[24] B. Ellenbroek,et al. Rodent models in neuroscience research: is it a rat race? , 2016, Disease Models & Mechanisms.
[25] H. Nguyen,et al. B46 The HD-like type 4/SCA17 disease protein TBP is cleaved by calpains in vitro and in vivo , 2016 .
[26] Elisavet I. Kyriakou,et al. Automated quantitative analysis to assess motor function in different rat models of impaired coordination and ataxia , 2016, Journal of Neuroscience Methods.
[27] I. J. Pinter,et al. Novel approach to automatically classify rat social behavior using a video tracking system , 2016, Journal of Neuroscience Methods.
[28] Jennie R. Green,et al. Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome , 2016, Human molecular genetics.
[29] J. Silverman,et al. Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders , 2016, PloS one.
[30] T. Kimchi,et al. From classic ethology to modern neuroethology: overcoming the three biases in social behavior research , 2016, Current Opinion in Neurobiology.
[31] L. Guarente,et al. Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathway , 2016, Nature Communications.
[32] S. Leng,et al. Rapamycin increases grip strength and attenuates age-related decline in maximal running distance in old low capacity runner rats , 2016, Aging.
[33] S. Dunnett,et al. Systematic and detailed analysis of behavioural tests in the rat middle cerebral artery occlusion model of stroke: Tests for long-term assessment , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] O. Riess,et al. The calpain-suppressing effects of olesoxime in Huntington's disease , 2016, Rare diseases.
[35] Shihua Li,et al. Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis , 2016, Rare diseases.
[36] Shenmin Zhang,et al. Studying polyglutamine diseases in Drosophila , 2015, Experimental Neurology.
[37] C. Calaminus,et al. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat. , 2015, Brain : a journal of neurology.
[38] Emmeke Aarts,et al. The light spot test: Measuring anxiety in mice in an automated home-cage environment , 2015, Behavioural Brain Research.
[39] Ji-feng Guo,et al. Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice. , 2015, Cell reports.
[40] Edith V. Sullivan,et al. Cross-sectional versus longitudinal estimates of age-related changes in the adult brain: overlaps and discrepancies , 2015, Neurobiology of Aging.
[41] Patrick L Wintrode,et al. Enhanced Molecular Mobility of Ordinarily Structured Regions Drives Polyglutamine Disease* , 2015, The Journal of Biological Chemistry.
[42] B. Spruijt,et al. Ethological concepts enhance the translational value of animal models. , 2015, European journal of pharmacology.
[43] A. Calas,et al. Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease , 2015, Metabolic Brain Disease.
[44] Jinn-Moon Yang,et al. The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment. , 2015, Neurotoxicology.
[45] J. Barrett,et al. The pain of pain: challenges of animal behavior models. , 2015, European journal of pharmacology.
[46] W. Krzyzosiak,et al. The Role of the Immune System in Triplet Repeat Expansion Diseases , 2015, Mediators of inflammation.
[47] H. Orr,et al. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1 , 2015, Neuroscience.
[48] Claire Richardson,et al. The power of automated behavioural homecage technologies in characterizing disease progression in laboratory mice: A review , 2015 .
[49] H. Hsieh-Li,et al. Deactivation of TBP contributes to SCA17 pathogenesis. , 2014, Human molecular genetics.
[50] D. Kaufer,et al. Stress, social behavior, and resilience: Insights from rodents , 2014, Neurobiology of Stress.
[51] T. Mikkelsen,et al. SCA 17 phenotype with intermediate triplet repeat number , 2014, Journal of the Neurological Sciences.
[52] G. Koutsis,et al. From Mild Ataxia to Huntington Disease Phenocopy: The Multiple Faces of Spinocerebellar Ataxia 17 , 2014, Case reports in neurological medicine.
[53] P. Perona,et al. Toward a Science of Computational Ethology , 2014, Neuron.
[54] A. Sowa,et al. From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease , 2014, BioMed research international.
[55] I. Golani,et al. Display of individuality in avoidance behavior and risk assessment of inbred mice , 2014, Front. Behav. Neurosci..
[56] B. Davidson,et al. Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] Berry M. Spruijt,et al. Reproducibility and relevance of future behavioral sciences should benefit from a cross fertilization of past recommendations and today's technology: “Back to the future” , 2014, Journal of Neuroscience Methods.
[58] O. Riess,et al. Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease , 2014, Journal of Neuroscience Methods.
[59] S. Koekkoek,et al. Cerebellar control of gait and interlimb coordination , 2014, Brain Structure and Function.
[60] A. Ennaceur. Tests of unconditioned anxiety — Pitfalls and disappointments , 2014, Physiology & Behavior.
[61] L. Vanderschuren,et al. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats , 2014, European Neuropsychopharmacology.
[62] Niklas Marklund,et al. Structured evaluation of rodent behavioral tests used in drug discovery research , 2014, Front. Behav. Neurosci..
[63] Yan Wang,et al. Social interaction with a cagemate in pain facilitates subsequent spinal nociception via activation of the medial prefrontal cortex in rats , 2014, PAIN®.
[64] Bror Alstermark,et al. Skilled Reaching and Grasping in the Rat: Lacking Effect of Corticospinal Lesion , 2014, Front. Neurol..
[65] Elad Schneidman,et al. Correction: High-order social interactions in groups of mice , 2014, eLife.
[66] W. Krzyzosiak,et al. Oligonucleotide-based strategies to combat polyglutamine diseases , 2014, Nucleic acids research.
[67] Christina A. Wilson,et al. Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia , 2014, European Neuropsychopharmacology.
[68] H. Harn,et al. Polyglutamine (PolyQ) Diseases: Genetics to Treatments , 2014, Cell transplantation.
[69] C. Belzung. Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects? , 2014, Neuropsychopharmacology.
[70] L. Vanderschuren,et al. Social play behavior, ultrasonic vocalizations and their modulation by morphine and amphetamine in Wistar and Sprague-Dawley rats , 2014, Psychopharmacology.
[71] Annemieke Aartsma-Rus,et al. Assessing functional performance in the mdx mouse model. , 2014, Journal of visualized experiments : JoVE.
[72] Shihua Li,et al. Age-Dependent Decrease in Chaperone Activity Impairs MANF Expression, Leading to Purkinje Cell Degeneration in Inducible SCA17 Mice , 2014, Neuron.
[73] A. Lees,et al. Late onset ataxia: MSA‐C or SCA 17? A gene penetrance dilemma , 2014, Movement disorders : official journal of the Movement Disorder Society.
[74] P. Bickford,et al. Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia , 2013, Neuropharmacology.
[75] M. Merello,et al. Autosomal dominant cerebellar ataxias: A systematic review of clinical features , 2013, Journal of the Neurological Sciences.
[76] H. Paulson,et al. Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[77] P. Rustin,et al. Friedreich's Ataxia, Frataxin, PIP5K1B: Echo of a Distant Fracas , 2013, Oxidative medicine and cellular longevity.
[78] Vittorio Murino,et al. Automatic Visual Tracking and Social Behaviour Analysis with Multiple Mice , 2013, PloS one.
[79] O. Riess,et al. Automated home cage assessment shows behavioral changes in a transgenic mouse model of spinocerebellar ataxia type 17 , 2013, Behavioural Brain Research.
[80] R. Schreiber,et al. Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease , 2013, PloS one.
[81] P. Corr. Approach and Avoidance Behaviour: Multiple Systems and their Interactions , 2013 .
[82] I. Guzhova,et al. Pharmacological protein targets in polyglutamine diseases: Mutant polypeptides and their interactors , 2013, FEBS letters.
[83] O. Feinerman,et al. Automated long-term tracking and social behavioural phenotyping of animal colonies within a semi-natural environment , 2013, Nature Communications.
[84] Mariam Alaverdashvili,et al. A behavioral method for identifying recovery and compensation: Hand use in a preclinical stroke model using the single pellet reaching task , 2013, Neuroscience & Biobehavioral Reviews.
[85] C. Calaminus,et al. A Novel Transgenic Rat Model for Spinocerebellar Ataxia Type 17 Recapitulates Neuropathological Changes and Supplies In Vivo Imaging Biomarkers , 2013, The Journal of Neuroscience.
[86] A. Kubatiev,et al. Increased Cell Fusion in Cerebral Cortex May Contribute to Poststroke Regeneration , 2013, Stroke research and treatment.
[87] F. Chaouloff. Social stress models in depression research: what do they tell us? , 2013, Cell and Tissue Research.
[88] I. Tarkka,et al. Gait Impairment in a Rat Model of Focal Cerebral Ischemia , 2013, Stroke research and treatment.
[89] Kai Vogeley,et al. Towards a neuroscience of social interaction , 2013, Front. Hum. Neurosci..
[90] C. Richter,et al. Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3). , 2013, Human molecular genetics.
[91] F. Tortella,et al. Longitudinal assessment of gait abnormalities following penetrating ballistic-like brain injury in rats , 2013, Journal of Neuroscience Methods.
[92] Kristin Branson,et al. JAABA: interactive machine learning for automatic annotation of animal behavior , 2013, Nature Methods.
[93] Yoav Benjamini,et al. Measuring behavior of animal models: faults and remedies , 2012, Nature Methods.
[94] B. Spruijt,et al. High‐throughput phenotyping of avoidance learning in mice discriminates different genotypes and identifies a novel gene , 2012, Genes, brain, and behavior.
[95] Wojciech J. Szlachcic,et al. Mouse Models of Polyglutamine Diseases: Review and Data Table. Part I , 2012, Molecular Neurobiology.
[96] A. Bird,et al. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. , 2012, Brain : a journal of neurology.
[97] L. Friberg,et al. Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: A case report , 2012, BMC Neurology.
[98] L. Schöls,et al. PET and MRI Reveal Early Evidence of Neurodegeneration in Spinocerebellar Ataxia Type 17 , 2012, The Journal of Nuclear Medicine.
[99] Olaf Riess,et al. Automated behavioral phenotyping reveals presymptomatic alterations in a SCA3 genetrap mouse model. , 2012, Journal of genetics and genomics = Yi chuan xue bao.
[100] Martin L. Duennwald,et al. Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin , 2012, PloS one.
[101] A. Bonnet,et al. Tremor-spectrum in spinocerebellar ataxia type 3 , 2012, Journal of Neurology.
[102] M. H. Angelis,et al. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb , 2012, Experimental Neurology.
[103] A. Meisel,et al. Gait analysis as a method for assessing neurological outcome in a mouse model of stroke , 2012, Journal of Neuroscience Methods.
[104] A. Cressant,et al. Computerized video analysis of social interactions in mice , 2012, Nature Methods.
[105] Lori-Ann R. Sacrey,et al. The use of rodent skilled reaching as a translational model for investigating brain damage and disease , 2012, Neuroscience & Biobehavioral Reviews.
[106] Adam Claridge‐Chang,et al. The surveillance state of behavioral automation , 2012, Current Opinion in Neurobiology.
[107] M. Paulus,et al. Executive function and PTSD: Disengaging from trauma , 2012, Neuropharmacology.
[108] Y. Temel,et al. Automated gait analysis in bilateral Parkinsonian rats and the role of l-DOPA therapy , 2012, Behavioural Brain Research.
[109] Alexander Klein,et al. Analysis of Skilled Forelimb Movement in Rats: The Single Pellet Reaching Test and Staircase Test , 2012, Current protocols in neuroscience.
[110] T. Steimer,et al. Animal models of anxiety disorders in rats and mice: some conceptual issues , 2011, Dialogues in clinical neuroscience.
[111] T. Wannier,et al. Behavioral Assessment of Manual Dexterity in Non-Human Primates , 2011, Journal of visualized experiments : JoVE.
[112] C. Belzung,et al. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression , 2011, Biology of Mood & Anxiety Disorders.
[113] M. Seshadri,et al. Spinocerebellar ataxia type 17 in Indian patients: two rare cases of homozygous expansions , 2011, Clinical genetics.
[114] L. Lu,et al. A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome. , 2011, Human molecular genetics.
[115] H. Hsieh-Li,et al. Neuroprotective effects of granulocyte‐colony stimulating factor in a novel transgenic mouse model of SCA17 , 2011, Journal of neurochemistry.
[116] Joseph J. Ling,et al. Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. , 2011, Brain : a journal of neurology.
[117] I. Liberzon,et al. The Neurocircuitry of Fear, Stress, and Anxiety Disorders , 2011, Neuropsychopharmacology.
[118] Jane S. Paulsen,et al. Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease , 2011, PLoS currents.
[119] Z. Wszolek,et al. Autosomal dominant cerebellar ataxia type I: A review of the phenotypic and genotypic characteristics , 2011, Orphanet journal of rare diseases.
[120] R. Schiffmann,et al. Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 Mice , 2011, PloS one.
[121] L. Peltonen,et al. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland , 2011, European Journal of Human Genetics.
[122] J. Roder,et al. Assessment of Social Interaction Behaviors , 2011, Journal of visualized experiments : JoVE.
[123] J. Guralnik,et al. Translating Research to Promote Healthy Aging: The Complementary Role of Longitudinal Studies and Clinical Trials , 2010, Journal of the American Geriatrics Society.
[124] L. Vanderschuren,et al. The pleasures of play: pharmacological insights into social reward mechanisms. , 2010, Trends in pharmacological sciences.
[125] P. Maciel,et al. Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products , 2010, Neurobiology of Disease.
[126] L. Cipolotti,et al. A Preliminary Characterisation of Cognition and Social Cognition in Spinocerebellar Ataxia Types 2, 1, and 7 , 2010, Behavioural neurology.
[127] Koen Van Laere,et al. Automated quantitative gait analysis in animal models of movement disorders , 2010, BMC Neuroscience.
[128] S. Savitz,et al. Functional assessments in the rodent stroke model , 2010, Experimental & Translational Stroke Medicine.
[129] C. Lichy,et al. Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[130] N. Müller,et al. Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease , 2010, International journal of Alzheimer's disease.
[131] G. Garden,et al. A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia , 2010, Journal of visualized experiments : JoVE.
[132] Shihua Li,et al. Polyglutamine toxicity in non-neuronal cells , 2010, Cell Research.
[133] S. Cardoso,et al. Dysfunctional mitochondria uphold calpain activation: Contribution to Parkinson's disease pathology , 2010, Neurobiology of Disease.
[134] Chuan-en Wang,et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.
[135] Shihua Li,et al. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17. , 2009, Human molecular genetics.
[136] N. Nukina,et al. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies , 2009, Journal of neurochemistry.
[137] Makoto Hashimoto,et al. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. , 2009, Inflammation & allergy drug targets.
[138] Shihua Li,et al. Activation of Gene Transcription by Heat Shock Protein 27 May Contribute to Its Neuronal Protection* , 2009, The Journal of Biological Chemistry.
[139] Antonio Krüger,et al. Behavioral phenotyping of a murine model of Alzheimer’s disease in a seminaturalistic environment using RFID tracking , 2009, Behavior research methods.
[140] A. H. Veenema,et al. Maternal separation enhances offensive play-fighting, basal corticosterone and hypothalamic vasopressin mRNA expression in juvenile male rats , 2009, Psychoneuroendocrinology.
[141] J. Marsh,et al. Animal Models of Polyglutamine Diseases and Therapeutic Approaches* , 2009, Journal of Biological Chemistry.
[142] G. Walenkamp,et al. The CatWalk method: Assessment of mechanical allodynia in experimental chronic pain , 2009, Behavioural Brain Research.
[143] T. Suuronen,et al. Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors , 2009, Progress in Neurobiology.
[144] R. Shin,et al. Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice , 2008, Human molecular genetics.
[145] S. Ferdinandusse,et al. Ataxia with loss of Purkinje cells in a mouse model for Refsum disease , 2008, Proceedings of the National Academy of Sciences.
[146] M. Chesselet,et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice , 2008, Neuroscience.
[147] J. Hermsdörfer,et al. Impairments of prehension kinematics and grasping forces in patients with cerebellar degeneration and the relationship to cerebellar atrophy , 2008, Clinical Neurophysiology.
[148] J. Castro-Lopes,et al. Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a clinically relevant study. , 2008, The journal of pain : official journal of the American Pain Society.
[149] F.P.T. Hamers,et al. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib , 2008, Journal of Neuroscience Methods.
[150] R. Paylor,et al. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents , 2008, Behavioural pharmacology.
[151] I. Whishaw,et al. The problem of relating plasticity and skilled reaching after motor cortex stroke in the rat , 2008, Behavioural Brain Research.
[152] G. Brook,et al. CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury , 2008, Journal of Neuroscience Methods.
[153] M. Hayden,et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease , 2008, The Journal of experimental medicine.
[154] Charlotte C. Burn,et al. What is it like to be a rat? Rat sensory perception and its implications for experimental design and rat welfare , 2008 .
[155] T. Yeh,et al. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation , 2008, Neurobiology of Disease.
[156] N. Banik,et al. Calpain as a potential therapeutic target in Parkinson's disease. , 2008, CNS & neurological disorders drug targets.
[157] W. Streit,et al. Microglial degeneration in the aging brain--bad news for neurons? , 2008, Frontiers in bioscience : a journal and virtual library.
[158] L. Spear,et al. Social interactions in adolescent and adult Sprague–Dawley rats: Impact of social deprivation and test context familiarity , 2008, Behavioural Brain Research.
[159] Chuan-en Wang,et al. Polyglutamine Expansion Reduces the Association of TATA-binding Protein with DNA and Induces DNA Binding-independent Neurotoxicity* , 2008, Journal of Biological Chemistry.
[160] J. Opitz,et al. X‐linked congenital ataxia: A new locus maps to Xq25‐q27.1 , 2008, American journal of medical genetics. Part A.
[161] M. DeLegge,et al. Neurodegeneration and Inflammation. , 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[162] G. Brook,et al. Strain and locomotor speed affect over-ground locomotion in intact rats , 2007, Physiology & Behavior.
[163] S. Warren,et al. Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration , 2007, Nature Neuroscience.
[164] M. Diamond,et al. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. , 2007, Human molecular genetics.
[165] C. Lovati,et al. Spinocerebellar ataxia type 17 (SCA17): Oculomotor phenotype and clinical characterization of 15 Italian patients , 2007, Journal of Neurology.
[166] Chiara Gagliardi,et al. Disorders of cognitive and affective development in cerebellar malformations. , 2007, Brain : a journal of neurology.
[167] A. Etkin,et al. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. , 2007, The American journal of psychiatry.
[168] Y. Temel,et al. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats , 2007, Neuroscience.
[169] M. Vamos,et al. The impact of Huntington's disease on family life. , 2007, Psychosomatics.
[170] M. Marcus,et al. The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection , 2007, Journal of Neuroscience Methods.
[171] Howard Schulman,et al. Global changes to the ubiquitin system in Huntington's disease , 2007, Nature.
[172] L. Rüttiger,et al. Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo Evidence , 2007, The Journal of Neuroscience.
[173] F. Hartl,et al. Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3* , 2007, Journal of Biological Chemistry.
[174] H. Zoghbi,et al. Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.
[175] G. Walenkamp,et al. The CatWalk method: A detailed analysis of behavioral changes after acute inflammatory pain in the rat , 2007, Journal of Neuroscience Methods.
[176] K. Gwinn‐Hardy,et al. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. , 2007, Parkinsonism & related disorders.
[177] Garet P. Lahvis,et al. Affiliative Behavior, Ultrasonic Communication and Social Reward Are Influenced by Genetic Variation in Adolescent Mice , 2007, PloS one.
[178] Rodney C. Samaco,et al. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes , 2007, Nature Genetics.
[179] P. Thier,et al. Specific influences of cerebellar dysfunctions on gait. , 2007, Brain : a journal of neurology.
[180] J. Schwankhaus,et al. Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA‐binding protein (TBP) gene , 2007, Movement disorders : official journal of the Movement Disorder Society.
[181] J. Henderson,et al. Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease , 2007, Journal of Neuroscience Methods.
[182] C. Lowry,et al. Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex , 2006, Brain Research Bulletin.
[183] A. Parent,et al. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. , 2006, Brain : a journal of neurology.
[184] Shelley E. Taylor. Tend and Befriend , 2006 .
[185] Ronald Wetzel,et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.
[186] A. Barrientos,et al. Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. , 2006, Human molecular genetics.
[187] U Walter,et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). , 2006, Brain : a journal of neurology.
[188] Harry T Orr,et al. Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. , 2006, Genes & development.
[189] L. de Visser,et al. Novel approach to the behavioural characterization of inbred mice: automated home cage observations , 2006, Genes, brain, and behavior.
[190] M. Tuszynski,et al. A form of motor cortical plasticity that correlates with recovery of function after brain injury. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[191] Berry M Spruijt,et al. Advanced behavioural screening: automated home cage ethology. , 2006, Drug discovery today. Technologies.
[192] F.P.T. Hamers,et al. CatWalk-assisted gait analysis in the assessment of spinal cord injury. , 2006, Journal of neurotrauma.
[193] R. Snell,et al. TATA-binding protein in neurodegenerative disease , 2005, Neuroscience.
[194] P. Chinnery,et al. Minimum prevalence of spinocerebellar ataxia 17 in the north east of England , 2005, Journal of the Neurological Sciences.
[195] S. McMahon,et al. Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice , 2005, Experimental Neurology.
[196] H. Urbach,et al. Putamen dopamine transporter and glucose metabolism are reduced in SCA17 , 2005, Annals of neurology.
[197] Bastiaan R Bloem,et al. Trunk sway in patients with spinocerebellar ataxia , 2005, Movement disorders : official journal of the Movement Disorder Society.
[198] E. Schwinger,et al. Spinocerebellar ataxia type 17: Report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes , 2005, BMC Medical Genetics.
[199] P. Boguszewski,et al. Expression of c-Fos in response to stressogenic stimuli in the amygdala of old vs. young rats--a preliminary study. , 2005, Acta neurobiologiae experimentalis.
[200] D. Nowak,et al. Preserved and impaired aspects of predictive grip force control in cerebellar patients , 2005, Clinical Neurophysiology.
[201] M. Savontaus,et al. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population , 2005, Acta neurologica Scandinavica.
[202] A. Zeman,et al. Neurological syndromes which can be mistaken for psychiatric conditions , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[203] A. Kalueff,et al. Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs. , 2005, European journal of pharmacology.
[204] Niels Kuster,et al. Whole-body exposure to 2.45GHz electromagnetic fields does not alter anxiety responses in rats: a plus-maze study including test validation , 2005, Behavioural Brain Research.
[205] Mark R. Segal,et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.
[206] Charles Duyckaerts,et al. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. , 2004, Archives of neurology.
[207] M. Schwab,et al. Behavioral testing strategies in a localized animal model of multiple sclerosis , 2004, Journal of Neuroimmunology.
[208] Michael S Fanselow,et al. Light stimulus change evokes an activity response in the rat , 2004, Learning & behavior.
[209] Peter Breuer,et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. , 2004, Molecular cell.
[210] S. Sorbi,et al. Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease‐like and ataxia , 2004, Annals of neurology.
[211] S. Hesse,et al. Basal ganglia involvement of a patient with SCA 17 , 2004, Journal of Neurology.
[212] M. Hayden,et al. Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity , 2004, Journal of Biological Chemistry.
[213] Thorsten Schmidt,et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.
[214] E. Nestler,et al. Neurobehavioral assessment in the information age , 2004, Nature Neuroscience.
[215] Alison Abbott,et al. Laboratory animals: The Renaissance rat , 2004, Nature.
[216] M. Mattson,et al. Paroxetine retards disease onset and progression in Huntingtin mutant mice , 2004, Annals of neurology.
[217] A. Ristić,et al. Spinocerebellar ataxia type 17 in the Yugoslav population , 2004, Acta neurologica Scandinavica.
[218] Osamu Onodera,et al. SCA17 homozygote showing Huntington's disease‐like phenotype , 2004, Annals of neurology.
[219] M. Oda,et al. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. , 2004, Archives of neurology.
[220] Christine Klein,et al. Focal dystonia as a presenting sign of spinocerebellar ataxia 17 , 2004, Movement disorders : official journal of the Movement Disorder Society.
[221] G. Coppola,et al. Intergenerational instability and marked anticipation in SCA-17 , 2003, Neurology.
[222] G. De Michele,et al. Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17 , 2003, Neurological Sciences.
[223] Olaf Riess,et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) , 2003, Annals of neurology.
[224] M. Sirard,et al. Making recombinant proteins in animals--different systems, different applications. , 2003, Trends in biotechnology.
[225] A. Morton,et al. Microglia density decreases with age in a mouse model of Huntington's disease , 2003, Glia.
[226] E. Schwinger,et al. SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6 , 2003, European Journal of Human Genetics.
[227] M. Hayden,et al. Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1 , 2003, Neuron.
[228] A. Durr,et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. , 2003, Brain : a journal of neurology.
[229] M. Owen,et al. Molecular investigation of TBP allele length: a SCA17 cellular model and population study , 2003, Neurobiology of Disease.
[230] R. Landgraf. Animal models of anxiety. , 2003, Stress.
[231] A. Konnerth,et al. Calbindin in Cerebellar Purkinje Cells Is a Critical Determinant of the Precision of Motor Coordination , 2003, The Journal of Neuroscience.
[232] Thomas Walther,et al. Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.
[233] S. File,et al. A review of 25 years of the social interaction test. , 2003, European journal of pharmacology.
[234] C. Belzung,et al. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.
[235] M. Hascöet,et al. The mouse light/dark box test. , 2003, European journal of pharmacology.
[236] T. Sharp,et al. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs , 2003, Biological Psychiatry.
[237] E. Schwinger,et al. Phenotypical variability of expanded alleles in the TATA-binding protein gene , 2003, Journal of Neurology.
[238] Ian Q Whishaw,et al. A Novel Skilled-Reaching Impairment in Paw Supination on the “Good” Side of the Hemi-Parkinson Rat Improved with Rehabilitation , 2003, The Journal of Neuroscience.
[239] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[240] T. Steimer,et al. The biology of fear- and anxiety-related behaviors , 2002, Dialogues in clinical neuroscience.
[241] G. Deuschl,et al. Typical features of cerebellar ataxic gait , 2002, Journal of neurology, neurosurgery, and psychiatry.
[242] M. Difiglia. Huntingtin fragments that aggregate go their separate ways. , 2002, Molecular cell.
[243] Ian Q. Whishaw,et al. Animal models of neurological deficits: how relevant is the rat? , 2002, Nature Reviews Neuroscience.
[244] L. Ellerby,et al. Calpain Activation in Huntington's Disease , 2002, The Journal of Neuroscience.
[245] M. Pook,et al. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. , 2002, Human molecular genetics.
[246] C. Broeckhoven,et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. , 2001, Brain : a journal of neurology.
[247] T. Klockgether,et al. Inflammatory Genes Are Upregulated in Expanded Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains , 2001, The Journal of Neuroscience.
[248] I. Kanazawa,et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.
[249] P. M. Wall,et al. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior , 2001, Neuroscience & Biobehavioral Reviews.
[250] H. Orr,et al. Beyond the Qs in the polyglutamine diseases. , 2001, Genes & development.
[251] P. Vieregge,et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia , 2001, European Journal of Human Genetics.
[252] S. Tsuji,et al. Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease , 2001, Acta Neuropathologica.
[253] M. Hascöet,et al. The mouse ligth-dark paradigm: A review , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[254] R. Albin,et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. , 2001, Human molecular genetics.
[255] C. Ross,et al. Widespread occurrence of intranuclear atrophin‐1 accumulation in the central nervous system neurons of patients with dentatorubral‐pallidoluysian atrophy , 2001, Annals of neurology.
[256] P. Lang,et al. Fear and anxiety: animal models and human cognitive psychophysiology. , 2000, Journal of affective disorders.
[257] S. Tsuji,et al. Pathology of CAG repeat diseases , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.
[258] Volker Dietz,et al. Efficient testing of motor function in spinal cord injured rats , 2000, Brain Research.
[259] S. Pulst,et al. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human , 2000, Nature Genetics.
[260] R. Christopher,et al. Trinucleotide repeats and neuropsychiatric disorders , 2000, Indian Journal of Clinical Biochemistry.
[261] M. Zvolensky,et al. Prediction and control: operational definitions for the experimental analysis of anxiety. , 2000, Behaviour research and therapy.
[262] E. Bertini,et al. X-linked congenital ataxia: a clinical and genetic study. , 2000, American journal of medical genetics.
[263] D. Riva,et al. The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours. , 2000, Brain : a journal of neurology.
[264] H. Zoghbi,et al. Fourteen and counting: unraveling trinucleotide repeat diseases. , 2000, Human molecular genetics.
[265] A. Holmes,et al. Corticosterone response to the plus-maze High correlation with risk assessment in rats and mice , 1999, Physiology & Behavior.
[266] Harry T Orr,et al. Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.
[267] M. McInnis,et al. Trinucleotide repeat expansion and neuropsychiatric disease. , 1999, Archives of general psychiatry.
[268] S Kobayashi,et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? , 1999, Human molecular genetics.
[269] H. Zoghbi,et al. Polyglutamine diseases: protein cleavage and aggregation , 1999, Current Opinion in Neurobiology.
[270] I. Kanazawa,et al. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. , 1999, Human molecular genetics.
[271] E. Tolosa,et al. Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. , 1999, Brain : a journal of neurology.
[272] D. Rubinsztein,et al. Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? , 1999, Journal of medical genetics.
[273] S. W. Davies,et al. Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation , 1999, Journal of neurochemistry.
[274] B. Moghaddam,et al. Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress , 1999, Journal of neurochemistry.
[275] S. Morato,et al. Ethopharmacological Analysis of 5-HT Ligands on the Rat Elevated Plus-Maze , 1999, Pharmacology Biochemistry and Behavior.
[276] Michael Davis,et al. Are different parts of the extended amygdala involved in fear versus anxiety? , 1998, Biological Psychiatry.
[277] C. Dourish,et al. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety , 1998, Neuroscience & Biobehavioral Reviews.
[278] Harry T Orr,et al. Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.
[279] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[280] H. Lipe,et al. Familial aggregation of schizophrenia-like symptoms in Huntington's disease. , 1998, American journal of medical genetics.
[281] M. Hascöet,et al. A New Approach to the Light/Dark Test Procedure in Mice , 1998, Pharmacology Biochemistry and Behavior.
[282] Dale E. Bredesen,et al. Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract* , 1998, The Journal of Biological Chemistry.
[283] L. Vanderschuren,et al. The neurobiology of social play behavior in rats , 1997, Neuroscience & Biobehavioral Reviews.
[284] R. Rodgers. Animal models of 'anxiety': where next? , 1997, Behavioural pharmacology.
[285] M. Brandão,et al. Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze , 1997, Behavioural pharmacology.
[286] C. Belzung,et al. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety , 1997, Behavioural pharmacology.
[287] Richard Paylor,et al. Social Interaction and Sensorimotor Gating Abnormalities in Mice Lacking Dvl1 , 1997, Cell.
[288] G. Perrault,et al. Risk Assessment Behaviour: Evaluation of Utility in the Study of 5-HT-Related Drugs in the Rat Elevated Plus-Maze Test , 1997, Pharmacology Biochemistry and Behavior.
[289] S. Watson. Neuroendocrine and Behavioral Responses and Brain Pattern of c‐fos Induction Associated with Audiogenic Stress , 1997, Journal of neuroendocrinology.
[290] M. Hayden,et al. Of molecular interactions, mice and mechanisms: new insights into Huntington's disease. , 1997, Current opinion in neurology.
[291] A. Holmes,et al. Animal models of anxiety: an ethological perspective. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[292] R. Handa,et al. Age-related changes in c-fos mRNA induction after open-field exposure in the rat brain , 1997, Neurobiology of Aging.
[293] J. Higgins,et al. Brain MRI, lumbar CSF monoamine concentrations, and clinical descriptors of patients with spinocerebellar ataxia mutations. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[294] A. Diamond,et al. Evidence for the importance of dopamine for prefrontal cortex functions early in life. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[295] J. Hughes,et al. The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. , 1996, European journal of pharmacology.
[296] M. Hahn,et al. Issues in the genetics of social behavior: Revisited , 1996, Behavior genetics.
[297] F. Cirulli,et al. Affiliation in periadolescent rats: Behavioral and corticosterone response to social reunion with familiar or unfamiliar partners , 1996, Pharmacology Biochemistry and Behavior.
[298] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[299] I. Pollack,et al. Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. , 1995, Neurosurgery.
[300] M. MacDonald,et al. Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains , 1994, Neurobiology of Disease.
[301] R. Tjian,et al. Multiple regions of TBP participate in the response to transcriptional activators in vivo. , 1994, Genes & development.
[302] J. Beckmann,et al. The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. , 1994, Genomics.
[303] J. Costentin,et al. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions , 1994, Behavioural Brain Research.
[304] R. Rodgers,et al. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol , 1994, Psychopharmacology.
[305] G. Griebel,et al. The free‐exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia‐reducing drugs , 1993, Behavioural pharmacology.
[306] Y. Agid,et al. Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. , 1993, Brain : a journal of neurology.
[307] B. Gostout,et al. "Cryptic" repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. , 1993, American journal of human genetics.
[308] L. V. Zutphen,et al. Description and validation of a preference test system to evaluate housing conditions for laboratory mice , 1992 .
[309] P. Harper. The epidemiology of Huntington's disease , 1992, Human Genetics.
[310] J. Sutcliffe,et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.
[311] P. Brain,et al. Ethopharmacological studies on the effects of antihormones on rodent agonistic behavior with especial emphasis on progesterone , 1991, Neuroscience & Biobehavioral Reviews.
[312] Miloš Kršiak,et al. Ethopharmacology: A historical perspective , 1991, Neuroscience & Biobehavioral Reviews.
[313] D. S. Rath,et al. Trinucleotide repeat polymorphism at the human transcription factor IID gene. , 1991, Nucleic acids research.
[314] K. Fischbeck,et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.
[315] Masami Horikoshi,et al. Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID) , 1990, Nature.
[316] P. Lieberman,et al. Cloning of a transcriptionally active human TATA binding factor. , 1990, Science.
[317] R. Tjian,et al. Functional domains and upstream activation properties of cloned human TATA binding protein. , 1990, Science.
[318] C. Carter,et al. Effects of hormonal, sexual, and social history on mating and pair bonding in prairie voles , 1988, Physiology & Behavior.
[319] S. Kish,et al. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum , 1987, Annals of neurology.
[320] C. Finch,et al. Dopamine and Serotonin Systems in Human and Rodent Brain: Effects of Age and Neurodegenerative Disease , 1987, Journal of the American Geriatrics Society.
[321] Jaak Panksepp,et al. The psychobiology of play: Theoretical and methodological perspectives , 1984, Neuroscience & Biobehavioral Reviews.
[322] R. Niesink,et al. Short-term isolation increases social interactions of male rats: A parametric analysis , 1982, Physiology & Behavior.
[323] A. Harding. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. , 1982, Brain : a journal of neurology.
[324] J. Panksepp. The ontogeny of play in rats. , 1981, Developmental psychobiology.
[325] J. Panksepp,et al. Social deprivation and play in rats. , 1980, Behavioral and neural biology.
[326] S. File. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs , 1980, Journal of Neuroscience Methods.
[327] A. Borbély,et al. Daily pattern of sleep, motor activity and feeding in the rat: Effects of regular and gradually extended photoperiods , 1978, Journal of comparative physiology.
[328] S. File,et al. CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY? , 1978, British journal of pharmacology.
[329] Y. Teichman. Predisposition for anxiety and affiliation. , 1974, Journal of personality and social psychology.
[330] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[331] M. Manosevitz,et al. Birth order, anxiety, and affiliation during a crisis. , 1968, Journal of personality and social psychology.
[332] S. Glickman,et al. A biological theory of reinforcement. , 1967, Psychological review.
[333] D. Schonfield. Memory Changes with Age , 1965, Nature.
[334] A. Torres. Anxiety versus escape conditioning and tranquilizing action. , 1961, Journal of comparative and physiological psychology.
[335] P. Young. The role of affective processes in learning and motivation. , 1959, Psychological review.
[336] J. S. Brown,et al. Gradients of approach and avoidance responses and their relation to level of motivation. , 1948, Journal of comparative and physiological psychology.
[337] Marco Santochi,et al. Grasping , 2019, CIRP Encyclopedia of Production Engineering.
[338] M. Papp,et al. Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention. , 2016, Pharmacological research.
[339] S. Pellis,et al. Play, variation in play and the development of socially competent rats , 2016 .
[340] I. Golani,et al. Home Cage-Based Long-Term Monitoring of Fear in Mice: Novel Approach to Determine Individual Differences in Risk Assessment and Avoidance , 2014 .
[341] B. Ruggeri,et al. Animal models of human disease: challenges in enabling translation. , 2014, Biochemical pharmacology.
[342] F. Guimarães,et al. Animal models of anxiety disorders and stress. , 2013, Revista brasileira de psiquiatria.
[343] Jenni M. Karl,et al. Rodent Skilled Reaching for Modeling Pathological Conditions of the Human Motor System , 2011 .
[344] M. Wood,et al. Therapeutic gene silencing strategies for polyglutamine disorders. , 2010, Trends in genetics : TIG.
[345] Olaf Riess,et al. Neurobehavioral tests in rat models of degenerative brain diseases. , 2010, Methods in molecular biology.
[346] Jacqueline N. Crawley,et al. Anxiety-Related Behaviors in Mice , 2009 .
[347] P. Solli,et al. Longitudinal studies , 2009 .
[348] K. Bürk,et al. Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein , 2008, The Cerebellum.
[349] F. J. van der Staay,et al. Pathological anxiety in animals. , 2008, Veterinary journal.
[350] A. Brice,et al. Spinocerebellar ataxia 17 (SCA17) and Huntington’s disease-like 4 (HDL4) , 2008, The Cerebellum.
[351] A. Sterr,et al. Neurobiology of learning and memory , 2008 .
[352] B. Olatunji,et al. A functional analysis of danger and safety signals in anxiety disorders. , 2007, Clinical psychology review.
[353] A. Brice,et al. Spinocerebellar Ataxia 17 and Huntington's Disease-like 4 , 2006 .
[354] N. Garrett,et al. Striatal dopamine and homovanillic acid in Huntington's Disease , 2005, Journal of Neural Transmission.
[355] S. File,et al. Raised corticosterone in the rat after exposure to the elevated plus-maze , 2005, Psychopharmacology.
[356] John F. Cryan,et al. Model organisms: The ascent of mouse: advances in modelling human depression and anxiety , 2005, Nature Reviews Drug Discovery.
[357] J. Vale,et al. Trinucleotide Repeats in 202 Families With Ataxia , 2002 .
[358] Ashley Harms. Inflammation in Parkinson's disease. , 2001, Advances in neurology.
[359] R. Yolken,et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.
[360] H. Zoghbi,et al. Trinucleotide repeats: mechanisms and pathophysiology. , 2000, Annual review of genomics and human genetics.
[361] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[362] Harding Ae. Clinical features and classification of inherited ataxias. , 1993, Advances in neurology.
[363] R. Lister. Ethologically-based animal models of anxiety disorders. , 1990, Pharmacology & therapeutics.
[364] B. Olivier,et al. ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS , 1990, Drug metabolism and drug interactions.
[365] S. Pellis,et al. Different levels of complexity in the play-fighting by muroid rodents appear to result from different levels of intensity of attack and defense , 1989 .
[366] J. Gray,et al. The neuropsychology of anxiety. , 1985, Issues in mental health nursing.
[367] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[368] R. Kataky,et al. Citation for Published Item: Publisher's Copyright Statement: Use Policy , 2022 .
[369] Shay Ohayon,et al. Journal of Neuroscience Methods Automated Multi-day Tracking of Marked Mice for the Analysis of Social Behaviour , 2022 .